Introducing Blood Flow, a new feature of the VESL community where we discuss contemporary evidence in cardiovascular disease management and how to improve outcomes for patients. In this first episode, Dr. Robert Hegele reviews the role of Lp(a) as a risk predictor.

In this inaugural episode of Blood Flow, Dr. Robert Hegele reviews a section of the 2021 Canadian Dyslipidemia Guidelines addressing the role of Lp(a) as a risk predictor.

>> View the video [15 min]

This first episode of Blood Flow was emailed to all VESL members on Friday, June 4, and can be accessed online here.

View all Blood Flow episodes to date at